Search

everythinglearnresearchcommunity

for

Search:↓

Common baldness treatments include cosmetic methods, medication like minoxidil, and surgery, but no cure exists.

Recent hair loss research shows some progress, especially in understanding male pattern baldness, but effective treatments for many types of hair loss are still lacking.

TGF-β1 increases androgen receptor activity in hair loss, but Hic-5/ARA55 can counter this effect.

Minoxidil was promising for treating male and female pattern baldness in 1994, but more research on genetics and other treatments was needed.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

Male pattern hair loss may be linked to the developmental origins of hair follicles.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

UV light does not significantly affect minoxidil's ability to treat male pattern baldness.

Monascus helps prevent baldness, prostate issues, and may be a natural alternative to medications.

New finasteride solution effectively reduces baldness-causing hormone, potentially with fewer side effects.

Chronic exposure to sunlight may worsen male pattern baldness and protecting the scalp from the sun could slow it down.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

Male pattern baldness is linked to higher levels of a certain receptor in the scalp, which leads to the shrinking of blood vessels and hair loss. Early treatment targeting this receptor could be more effective.

Chemotherapy often causes patterned hair loss, with some scalp areas more resistant to hair loss than others.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Finasteride can cause muscle pain and high creatine kinase levels, but stopping the medication may resolve symptoms.

Bald men may have a lower risk of testicular cancer.

Targeting CXXC5 and GSK-3β may help treat male pattern baldness.

Protease Nexin-1 is found in human hair growth cells and is affected by male hormones.

Excessive hair growth in women can be treated with medications like spironolactone and finasteride, and male-pattern baldness in women can be improved with similar treatments.

Testosterone can both promote hair growth and cause baldness by affecting hair growth signals.

Chemotherapy can cause permanent, non-reversible hair loss similar to pattern baldness.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

D-004 may be a natural alternative to finasteride for treating enlarged prostate and male baldness.

Cells from balding scalps have more androgen receptors than cells from non-balding scalps.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

The conclusion is that small hair follicles cause baldness in macaques, and treatments like antiandrogens and minoxidil can prevent hair loss and promote regrowth.

Male pattern baldness is caused by certain cells in hair follicles and could potentially be treated by targeting a specific growth factor, TGF-β1.